Venus Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 200.81 | 184.19 | 177.73 |
| Operating Expense | 171.49 | 149.63 | 156.75 |
| Net Profit | 14.79 | 24.08 | 9.26 |
| Net Profit Margin | 7.37 | 13.07 | 5.21 |
| Earning Per Share | 11.07 | 18.02 | 6.92 |
| EBIDTA | 27.49 | 36.66 | 19.15 |
| Effective Tax Rate | 28.00 | 21.35 | 17.73 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 200.81 |
| Operating Expense | 171.49 |
| Net Profit | 14.79 |
| Net Profit Margin | 7.37 |
| Earning Per Share | 11.07 |
| EBIDTA | 27.49 |
| Effective Tax Rate | 28.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 575.21 | 537.66 | 576.71 |
| Operating Expenses Annual | 514.32 | 476.14 | 507.89 |
| Operating Profit Annual | 72.21 | 71.70 | 77.25 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 16.51 | 22.61 | 23.82 |
| Net Profit Annual | 30.50 | 28.96 | 48.99 |
| Tax Annual | 16.15 | 11.36 | -4.32 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 575.21 |
| Operating Expenses Annual | 514.32 |
| Operating Profit Annual | 72.21 |
| Interest Annual | TBA |
| Depreciation | 16.51 |
| Net Profit Annual | 30.50 |
| Tax Annual | 16.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 20.07 | 42.83 | 27.70 |
| Cash Flow from Operations | 35.38 | 28.05 | 41 |
| Cash Flow from Investing | -6.94 | -50.81 | -16.75 |
| Cash Flow from Financing | TBA | TBA | -9.13 |
| Cash Flow at the End | 48.51 | 20.07 | 42.83 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 20.07 |
| Cash Flow from Operations | 35.38 |
| Cash Flow from Investing | -6.94 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 48.51 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 12.55 | 13.34 | 13.39 |
| PBIT Margin (%) | 8.11 | 7.50 | 7.75 |
| PBT Margin (%) | 8.11 | 7.50 | 7.75 |
| Net PROFIT Margin (%) | 5.30 | 5.39 | 8.49 |
| Return On Networth / Equity (%) | 6.18 | 6.24 | 11.53 |
| Return On Networth /Employed (%) | 8.61 | 7.89 | 9.39 |
| Return On Assets (%) | 5.62 | 5.66 | 10.28 |
| Total Debt / Equity (X) | 0.08 | 0.08 | 0.10 |
| Asset Turnover Ratio (%) | 1.06 | 1.05 | 1.21 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 12.55 |
| PBIT Margin (%) | 8.11 |
| PBT Margin (%) | 8.11 |
| Net PROFIT Margin (%) | 5.30 |
| Return On Networth / Equity (%) | 6.18 |
| Return On Networth /Employed (%) | 8.61 |
| Return On Assets (%) | 5.62 |
| Total Debt / Equity (X) | 0.08 |
| Asset Turnover Ratio (%) | 1.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 202.76 | 199.68 | 224.67 |
| Total Current Assets Annual | 361.00 | 318.19 | 264.41 |
| Non Current Assets Annual | 280.26 | 290.70 | 314.25 |
| Total Shareholders Funds Annual | 508.59 | 478.05 | 449.41 |
| Total Assets Annual | 641.26 | 608.89 | 578.66 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 202.76 |
| Total Current Assets Annual | 361.00 |
| Non Current Assets Annual | 280.26 |
| Total Shareholders Funds Annual | 508.59 |
| Total Assets Annual | 641.26 |
EPS (INR)
Expected
15.71
Reported
15.71
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
